PEAK6 Investments’s Avanos Medical AVNS Stock Holding History

PEAK6 Investments’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-15,500	Closed	-$309K	–	3548
2024 Q1	$309K	Buy	15,500 +3,700	+31%	+$71.5K	﹤0.01%	2774
2023 Q4	$265K	Buy	+11,800	New	+$244K	﹤0.01%	3055
2021 Q3	–	Sell	-9,700	Closed	-$353K	–	5136
2021 Q2	$353K	Hold	9,700	–	–	﹤0.01%	3544
2021 Q1	$424K	Sell	9,700 -6,400	-40%	-$300K	﹤0.01%	3357
2020 Q4	$739K	Buy	16,100 +10,600	+193%	+$441K	﹤0.01%	2751
2020 Q3	$183K	Buy	5,500 +1,900	+53%	+$60.7K	﹤0.01%	3549
2020 Q2	$106K	Sell	3,600 -200	-5%	-$5.79K	﹤0.01%	3772
2020 Q1	$102K	Buy	+3,800	New	+$113K	﹤0.01%	3291
2019 Q4	–	Sell	-30,900	Closed	-$1.16M	–	3374
2019 Q3	$1.16M	Buy	+30,900	New	+$1.18M	0.01%	1657
2019 Q1	–	Sell	-22,000	Closed	-$985K	–	3797
2018 Q4	$985K	Sell	22,000 -7,800	-26%	-$409K	0.01%	1782
2018 Q3	$2.04M	Buy	+29,800	New	+$1.92M	0.01%	1407

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

WHG

Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

PEAK6 Investments's AVNS Position: Q2 2024 in Review

PEAK6 Investments sold out of Avanos Medical (AVNS) in Q2 2024, closing a stake of 2,969 shares — an estimated $59.1K sold.

PEAK6 Investments first reported a position in AVNS in Q4 2018 and held it in 4 quarters. The position peaked at $456K in Q4 2021. 258 funds tracked by Wall St. Rank hold AVNS as of Q2 2024.

PEAK6 Investments reported no remaining Avanos Medical position as of Q2 2024 after selling out during the quarter.
PEAK6 Investments sold 2,969 Avanos Medical shares in Q2 2024, an estimated $59.1K.
PEAK6 Investments first reported a position in Avanos Medical in Q4 2018 and held it in 4 quarters.
PEAK6 Investments's Avanos Medical position peaked at $456K in Q4 2021.
258 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2024.

Based on PEAK6 Investments's 13F filing for Q2 2024, filed 14 Aug 2024.